THE EFFECT OF ANTI-TUMOR NECROSIS FACTOR THERAPY WITH GOLIMUMAB ON RADIOGRAPHIC PROGRESSION IN DEFINITE ANKYLOSING SPONDYLITIS: 4-YEAR RESULTS

被引：1
|
作者：
Braun, J. [1 ]
van der Heijde, D. [2 ]
Hermann, K. -G. [3 ]
Baraliakos, X. [4 ]
Deodhar, A. [5 ]
Beutler, A. [6 ]
Mack, M. [6 ]
Xu, W. [6 ]
Hsu, B. [6 ]
Inman, R. [7 ]
机构：
[1] Rheumazentrum Ruhrgebiet, Herne, Germany
[2] Leiden Univ, Med Ctr, Leiden, Netherlands
[3] Charite, Berlin, Germany
[4] Ruhr Univ Bochum, Ctr Rheumatol Herne, Bochum, Germany
[5] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[6] Janssen Res & Dev LLC, Spring House, PA USA
[7] Univ Toronto, Toronto, ON, Canada
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 71卷
关键词：
D O I：
10.1136/annrheumdis-2012-eular.2243
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：249 / 249
页数：1
相关论文
共 50 条
  • [21] The effect of two golimumab doses on radiographic progression in ankylosing spondylitis: results through 4 years of the GO-RAISE trial
    Braun, Juergen
    Baraliakos, Xenofon
    Hermann, Kay-Geert A.
    Deodhar, Atul
    van der Heijde, Desiree
    Inman, Robert
    Beutler, Anna
    Zhou, Yiying
    Xu, Stephen
    Hsu, Benjamin
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (06) : 1107 - 1113
  • [22] Effectiveness and safety of adalimumab in patients with ankylosing spondylitis or psoriatic arthritis and history of anti-tumor necrosis factor therapy
    Martin Rudwaleit
    Filip Van den Bosch
    Martina Kron
    Sonja Kary
    Hartmut Kupper
    Arthritis Research & Therapy, 12
  • [23] Effectiveness and safety of adalimumab in patients with ankylosing spondylitis or psoriatic arthritis and history of anti-tumor necrosis factor therapy
    Rudwaleit, Martin
    Van den Bosch, Filip
    Kron, Martina
    Kary, Sonja
    Kupper, Hartmut
    ARTHRITIS RESEARCH & THERAPY, 2010, 12 (03)
  • [24] Prevalence and Radiographic Progression of Hip Involvement in Patients With Ankylosing Spondylitis Treated With Tumor Necrosis Factor Inhibitors
    Konsta, Maria
    Nurmohamed, Michael T.
    Iliopoulos, Alexios
    Sfikakis, Petros P.
    van Denderen, J. Christiaan
    Visman, Ingrid
    Sakelariou, Grigorios T.
    van der Horst-Bruinsma, Irene E.
    JOURNAL OF RHEUMATOLOGY, 2023, 50 (03) : 342 - 350
  • [25] Dose Adjustment of Tumor Necrosis Factor Inhibitors Does Not Correlated with Radiographic Progression in Patients with Ankylosing Spondylitis
    Koo, Bon San
    Park, Seo Young
    Shin, Ji Hui
    Lee, Seunghun
    Bin Joo, Kyung
    Kim, Tae-Hwan
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1008 - 1009
  • [26] The effect of anti-tumor necrosis factor agents on sexual dysfunction in male patients with ankylosing spondylitis: a pilot study
    J S Oh
    H-M Heo
    Y-G Kim
    S G Lee
    C-K Lee
    B Yoo
    International Journal of Impotence Research, 2009, 21 : 372 - 375
  • [27] The effect of anti-tumor necrosis factor agents on sexual dysfunction in male patients with ankylosing spondylitis: a pilot study
    Oh, J. S.
    Heo, H-M
    Kim, Y-G
    Lee, S. G.
    Lee, C-K
    Yoo, B.
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2009, 21 (06) : 372 - 375
  • [28] Impact of anti-tumor necrosis factor treatment on lipid profiles in Korean patients with ankylosing spondylitis
    Kwon, Inbeom
    Choi, Nayeon
    Shin, Ji Hui
    Lee, Seunghun
    Nam, Bora
    Kim, Tae-Hwan
    JOURNAL OF RHEUMATIC DISEASES, 2024, 31 (01): : 41 - 48
  • [29] The Burden of Ankylosing Spondylitis and the Cost-Effectiveness of Anti-Tumor Necrosis Factor α Agents in Romania
    Ancuta, Ioan
    Codreanu, Catalin
    Ionescu, Ruxandra
    Parvu, Magda
    Bojinca, Mihai
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S596 - S597
  • [30] Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor α monoclonal antibody infliximab
    Brandt, J
    Haibel, H
    Cornely, D
    Golder, W
    Gonzalez, J
    Reddig, J
    Thriene, W
    Sieper, J
    Braun, J
    ARTHRITIS AND RHEUMATISM, 2000, 43 (06): : 1346 - 1352
12345